Tag: risk

23andMe Researcher Katie Huber

This is the first in an occasional series of profiles introducing you to the people behind 23andMe’s compelling research. Katie Huber is a scientist who spent years studying infectious diseases, like typhoid and anthrax. Here at 23andMe, she has the much less scary task of ensuring that our customers who ...

Read more

To Know Or Not To Know

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who received their health information prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will only have ...

Read more

Taking The Bull By The Horns

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who purchased prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will not. Those customers will have ...

Read more

The Power of Knowing

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who purchased prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will not. Those customers will have ...

Read more

23andMe Finds Few Negative Reactions to Genetic Tests For Cancer Mutations

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who received their health information prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will only have ...

Read more

World Alzheimer’s Day

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who purchased prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will not. Those customers will have ...

Read more

Confusion Over Utility of Common Genetic Variations in Breast Cancer Risk Prediction

A paper published in the New England Journal of Medicine (NEJM) this week, entitled "Performance of Common Genetic Variants in Breast-Cancer Risk Models," has led several media outlets to declare that common genetic variants have nothing to add when it comes to predicting breast cancer risk.  Here we'll ...

Read more

Return to top